| Literature DB >> 33673449 |
Ilaria Piano1, Mattia Di Paolo1,2, Francesca Corsi1,3, Eugenia Piragine1, Silvia Bisti2,4, Claudia Gargini1,2,5, Stefano Di Marco2,4.
Abstract
Retinal diseases can be induced by a variety of factors, including gene mutations, environmental stresses and dysmetabolic processes. The result is a progressive deterioration of visual function, which sometimes leads to blindness. Many treatments are under investigation, though results are still mostly unsatisfactory and restricted to specific pathologies, particularly in the case of gene therapy. The majority of treatments have been tested in animal models, but very few have progressed to human clinical trials. A relevant approach is to study the relation between the type of treatments and the degenerative characteristics of the animal model to better understand the effectiveness of each therapy. Here we compare the results obtained from different animal models treated with natural compounds (saffron and naringenin) to anticipate the potentiality of a single treatment in different pathologies.Entities:
Keywords: nutraceutical compounds; oxidative stress; preventative therapy; retinal degeneration
Year: 2021 PMID: 33673449 PMCID: PMC7997156 DOI: 10.3390/nu13030770
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717